Manuel Portero Otin
Grau: Doctor/a
973 702 408
manuel.portero(ELIMINAR)@udl.cat
ResearcherID: http://www.researcherid.com/rid/B-7122-2009
Publicacions
-
Uribarri J; Del Castillo MD; de la Maza MP; Filip R; Gugliucci A; Luevano-Contreras C; Macías-Cervantes MH; Markowicz Bastos DH; Medrano A; Menini T; Portero-Otin M; Rojas A; Sampaio GR; Wrobel K; Wrobel K; Garay-Sevilla ME
Dietary Advanced Glycation End Products and Their Role in Health and Disease
Advances in Nutrition 6 461-473. .
-
Serrano, JCE; Jove, M; Gonzalo, H; Pamplona, R; Portero-Otin, M
Nutridynamics: mechanism(s) of action of bioactive compounds and their effects
INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION 66 22-30. .
-
Naudí A; Cabré R; Jové M; Ayala V; Gonzalo H; Portero-Otín M; Ferrer I; Pamplona R
Lipidomics of Human Brain Aging and Alzheimer's Disease Pathology
International Review of Neurobiology 122 133-189. .
-
López-González I; Schlüter A; Aso E; Garcia-Esparcia P; Ansoleaga B; LLorens F; Carmona M; Moreno J; Fuso A; Portero-Otin M; Pamplona R; Pujol A; Ferrer I
Neuroinflammatory Signals in Alzheimer Disease and APP/PS1 Transgenic Mice: Correlations With Plaques, Tangles, and Oligomeric Species
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 74 319-344. .
-
Purroy, F; Jove, M; Portero, M; Cambray, S; Suarez, I; Sanahuja, J; Farre, J; Benabdelhak, I
Metabolomics discriminate etiologic subtypes among TIA patients
International Journal of Stroke 10 222-222. .
-
Ost M; Keipert S; van Schothorst EM; Donner V; van der Stelt I; Kipp AP; Petzke KJ; Jove M; Pamplona R; Portero-Otin M; Keijer J; Klaus S
Muscle mitohormesis promotes cellular survival via serine/glycine pathway flux
FASEB JOURNAL 29 1314-1328. .
-
Jové M; Mauri-Capdevila G; Suárez I; Cambray S; Sanahuja J; Quílez A; Farré J; Benabdelhak I; Pamplona R; Portero-Otín M; Purroy F
Metabolomics predicts stroke recurrence after transient ischemic attack
NEUROLOGY 84 36-45. .
-
Ansoleaga B; Jové M; Schlüter A; Garcia-Esparcia P; Moreno J; Pujol A; Pamplona R; Portero-Otín M; Ferrer I
Deregulation of purine metabolism in Alzheimer's disease
NEUROBIOLOGY OF AGING 36 68-80. .
-
Cacabelos, D.; Ayala, V.; Ramírez-Nunez, O.; Granado-Serrano, A.B.; Boada, J.; Serrano, J.C.E.; Cabré, R.; Nadal-Rey, G.; Bellmunt, M.J.; Ferrer, I.; Pamplona, R.; Portero-Otin, M.
Dietary Lipid Unsaturation Influences Survival and Oxidative Modifications of an Amyotrophic Lateral Sclerosis Model in a Gender-Specific Manner
NEUROMOLECULAR MEDICINE 16 669-685. .
-
Jové M; Naudí A; Portero-Otin M; Cabré R; Rovira-Llopis S; Bañuls C; Rocha M; Hernández-Mijares A; Victor VM; Pamplona R
Plasma lipidomics discloses metabolic syndrome with a specific HDL phenotype
FASEB JOURNAL 28 5163-5171. .
-
Blasco G; Puig J; Daunis-I-Estadella J; Molina X; Xifra G; Fernández-Aranda F; Pedraza S; Ricart W; Portero-Otín M; Fernández-Real JM
Brain Iron Overload, Insulin Resistance, and Cognitive Performance in Obese Subjects: A Preliminary MRI Case-Control Study
DIABETES CARE 37 3076-3083. .
-
Jové, M.; Naudí, A.; Ramírez-Núñez, O.; Portero-Otín, M.; Selman, C.; Withers, D.J.; Pamplona, R.
Caloric restriction reveals a metabolomic and lipidomic signature in liver of male mice
AGING CELL 13 828-837. .
Projectes
- Spanish Minor Stroke Perfusion Initiative: SMS-P Initiative
- Contractació de personal investigador predoctoral en formació (FI SDUR 2024)
- Ajuts Joan Oró per a la contractació de personal investigador predoctoral en formació FI 2025
- SEED-ALS: Synergizing Efforts to Develop and Accelerate Breakthroughs in ALS Research
- Natural microbicides from rice against current and emerging infectious diseases
- Personal predoctoral en formació UdL 2025
- Humanised mouse models to study ATG4B cryptic exon involvement in ALS pathogenesis and its potential as disease biomarker (Hum4ALS)
- Desregulacion de TDP-43,eje clave en la ELA: Caracterización de firmas lipidómicas, transcriptómicas y autofágicas en muestras específicas de pacientes para biomarcadores y reposicionamiento
- Targeting cryptic exons as biomarkers and ALS therapy
- Comprehensive Roadmap and Preclinical Evaluation of Antisense Oligonucleotides (ASOs) Regulatory Development and Toxicological Assessment for ALS Treatment
- The role of defects in mitochondria-associated ER membranes (MAM) to Amyotrophic Lateral Sclerosis
- Perspectivas clínicas de la biología de sistemas aplicada al análisis de placas carotídeas humanas: ILER-CAROTID